Objective:To summarize the prognosis in patients with acute ST elevation myocardial infarction (STEMI) and high glucose or type 2 diabetes. Method: The clinical data of 413 patients with STEMI from Jan 2010 to Sep 2013 were divided into normal glucose group (group A), high glucose group (group B) and type 2 diabetes group (group C). The prognosis among the three groups was analyzed. Results: The in-hospital mortality in group C and group B was significantly higher than that in group A (24.7% vs.9.4% ,P<0.05).The in-hospital re-infarction rate in group C was significantly higher than that in group B and group A (3.9% vs. 0.7% vs. 0%,P<0.05). Recurrent angina rate (23.4% vs.31.0% vs.14.7%,P<0.05),in-hospital heart failure rate (41.6% vs. 50.0% vs. 22.1%,P<0.05), in-hospitalmajor adverse cardiovascular events (MACE) rate ( 58.4% vs. 65.5% vs. 33.4%,P<0.05)and one year all cause mortality were higher (34.2% vs. 31.4% vs. 16.7%,P<0.05)in group C and group B were significantly higher than those in group A. Conclusion: Comparing with the patients with STEMI accompanying normal glucose, the prognosis of abnormal glucose metabolism were worse.%目的：总结急性 ST 段抬高型心肌梗死（STEMI）合并血糖代谢异常（2型糖尿病或就诊血糖升高）患者的预后。方法：回顾性分析2010年1月－2013年9月我科确诊 STEMI 患者413例的临床资料，比较血糖正常组（A 组）与就诊血糖升高组（B 组）、2型糖尿病组（C 组）的预后。结果：（B＋C）组住院期间死亡率明显高于 A组（24．7％ vs．9．4％，P＜0．05），C 组住院期间再发心肌梗死率明显高于 B 组和A 组（3．9％ vs．0％ vs．0．7％，P＜0．05）， C 组、B 组与A 组比较，再发心绞痛率（23．4％ vs．31．0％ vs．14．7％，P＜0．05）、住院期间心力衰竭率（41．6％ vs．50．0％ vs．22．1％，P＜0．05）、住院期间 MACE（58．4％ vs．65．5％ vs．33．4％，P＜0．05）及一年全因死亡率（34．2％ vs．31．4％ vs．16．7％，P＜0．05）发生率更高。结论：STEMI合并血糖代谢异常的预后差于血糖正常组。
展开▼
